Different Opioid Drugs Recruit Different Spinal Cord Peptides for Pain Relief | Research

The takeaway

Bremazocine's pain relief involves spinal dynorphin A and met-enkephalin release, while morphine's does not — showing distinct opioid drugs use different spinal pathways.

Distinct pathways
Bremazocine requires spinal dynorphin A and met-enkephalin release; morphine does not — same brain injection site, completely different spinal mechanisms

What the researchers found

Spinal dynorphin A and met-enkephalin mediate bremazocine's pain relief but not morphine's, showing distinct opioid signaling pathways.

Why it matters

This study shows that different opioid drugs recruit different natural pain peptides in the spinal cord. Understanding these distinct pathways could help develop pain treatments with fewer side effects.

How the study worked

Researchers injected bremazocine or morphine into mouse brains (intracerebroventricular). They then gave antibodies against specific opioid peptides into the spinal cord to see which peptides were needed for pain relief, measured by the tail-flick test.

What this study cannot tell us

This was an animal study in mice using direct brain injection, a route not used in humans. Results may not translate directly to human pain treatment.

How to read the evidence

Preliminary — animal study in mice with brain injection. Elegant pharmacological dissection but limited to one species and acute pain model.

When this study was published

Published in 1993 (33 years ago). The concept of multiple opioid analgesic pathways is now well-established.

The bigger picture

If different opioid drugs work through different spinal pathways, combining them might provide better pain relief. And drugs that recruit natural peptides like bremazocine might cause less tolerance than morphine.

Questions still open

Could combining bremazocine-type and morphine-type drugs provide synergistic pain relief?
Does recruiting natural spinal peptides cause less tolerance?

Common questions

Why do different opioid drugs use different pathways?

Bremazocine activates epsilon and kappa receptors in the brain, which send signals down the spinal cord that release dynorphin and enkephalin. Morphine primarily activates mu receptors using a different descending pathway. Same starting point, different wiring.

Could this improve pain treatment?

Yes — if drugs recruit non-overlapping spinal pathways, combining them might produce stronger pain relief than either alone, while potentially reducing the tolerance that limits individual drugs.

Read the original research

Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.

The Journal of pharmacology and experimental therapeutics, 266(3), 1430-8

View on PubMed ↗

Citation

Tseng, L F; Collins, K A. (1993). Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.. The Journal of pharmacology and experimental therapeutics, 266(3), 1430-8.